9LK-12634-36383
4 vaccinations
7 coded responses
22 check-ins
6 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 51-55
- ZIP prefix
- 165 / PA
- Registered
- 2021-03-30
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-06
Dose 1 — Pfizer-BioNTech
-
2021-03-27
Dose 2 — Pfizer-BioNTech
-
2021-03-30
Registered in v-safe
-
2021-03-30
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
-
2021-03-31
Survey response — days 1–6 daily, dose 2MedDRA: Dyskinesia — Feeling: Fair · Headache, Fatigue or tiredness · Be unable to do your normal daily activitiesFree text: Jerky movements of handsMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-01
Survey response — days 1–6 daily, dose 2MedDRA: Fatigue — Feeling: Fair · Headache, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activitiesFree text: Severe fatigueMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-02
Survey response — days 1–6 daily, dose 2MedDRA: Fatigue — Feeling: Fair · Headache, Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activitiesFree text: Severe fatigueMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-04-03
- 2021-04-10
- 2021-04-17
- 2021-04-24
- 2021-05-01
- 2021-05-08
- 2021-06-26
-
2021-09-25
Survey response — 6 months, dose 2MedDRA: Nausea — Feeling: Poor · Be unable to do your normal daily activitiesFree text: Bad nauseaMedDRA releases: 2024-11 · check-in free text available
-
2021-11-05
Dose 3 — Janssen/Johnson & Johnson
- 2022-03-27
-
2022-05-24
Dose 4 — Pfizer-BioNTech
- 2022-06-02
- 2022-06-07
- 2022-06-14
- 2022-06-21
- 2022-06-28
- 2022-07-05
-
2022-08-23
Survey response — 3 months, dose 4MedDRA: Ageusia, Anosmia, Arthralgia, Cough, Diarrhoea, Headache, Migraine, Oropharyngeal pain, Pain, Paranasal sinus hypersecretion, Pyrexia, Spinal pain — Feeling: Good · Be unable to do your normal daily activitiesFree text: Sore throat, fever, cough, spinal pain, migraine and headaches, intense body pain, diarrhea, joint pain (VERY INTENSE!!), loss of taste and smell, sinus drainageMedDRA releases: 2024-11 · check-in free text available
-
2022-11-22
Survey response — 6 months, dose 4MedDRA: Cognitive disorder, Condition aggravated, Fatigue, Memory impairment, Migraine, Nervous system disorder, Pre-existing disease, Pulmonary function test decreased — Feeling: Good · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Increased fatigue, memory/cognition issues increased, increased nervous system reactions, migraine issues increased, decreased lung function and more dependent on long term inhalers (from prn use to twice daily use).MedDRA releases: 2024-11 · check-in free text available
-
2022-11-22
Report sent to call center — 6 months, dose 4Be unable to do your normal daily activities · Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · 1 call case(s)
- 2022-11-23
-
2022-11-25
Callback requested for10:00AM ET
-
2022-11-25
Call successfulCompleted over the phone
-
2023-05-24
Survey response — 12 months, dose 4MedDRA: Malaise — Feeling: Fair · Be unable to do your normal daily activitiesMedDRA releases: 2024-11
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-06 | Pfizer-BioNTech | |
| 2 | 2021-03-27 | Pfizer-BioNTech | |
| 3 | 2021-11-05 | Janssen/Johnson & Johnson | No |
| 4 | 2022-05-24 | Pfizer-BioNTech | No |
Call center
1 call center case
1 successful
VAERS report filed, before or during a call: 1
Free text
Release 6 — days 1–6 daily, dose 2
Systemic reaction (other): Jerky movements of hands
Systemic reaction (other): Severe fatigue
Systemic reaction (other): Severe fatigue
Release 9 — 6 months, dose 2
Symptoms: Bad nausea
Release 12 — 3 months, dose 4
Symptoms: Sore throat, fever, cough, spinal pain, migraine and headaches, intense body pain, diarrhea, joint pain (VERY INTENSE!!), loss of taste and smell, sinus drainage
Release 12 — 6 months, dose 4
Symptoms: Increased fatigue, memory/cognition issues increased, increased nervous system reactions, migraine issues increased, decreased lung function and more dependent on long term inhalers (from prn use to twice daily use).
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Ageusia | · | · | ✓ |
| SD | Anosmia | · | · | ✓ |
| SD | Arthralgia | · | · | ✓ |
| SD | Cognitive disorder | · | · | ✓ |
| SD | Condition aggravated | · | · | ✓ |
| SD | Cough | · | · | ✓ |
| SD | Diarrhoea | · | · | ✓ |
| SD | Fatigue | · | · | ✓ |
| SD | Headache | · | · | ✓ |
| SD | Malaise | · | · | ✓ |
| SD | Memory impairment | · | · | ✓ |
| SD | Migraine | · | · | ✓ |
| SD | Nausea | · | · | ✓ |
| SD | Nervous system disorder | · | · | ✓ |
| SD | Oropharyngeal pain | · | · | ✓ |
| SD | Pain | · | · | ✓ |
| SD | Paranasal sinus hypersecretion | · | · | ✓ |
| SD | Pre-existing disease | · | · | ✓ |
| SD | Pulmonary function test decreased | · | · | ✓ |
| SD | Pyrexia | · | · | ✓ |
| SD | Spinal pain | · | · | ✓ |
| SRO | Dyskinesia | ✓ | ✓ | ✓ |
| SRO | Fatigue | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release